StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.11−0.06 (-5.13%)

Close on Nov 17, 2026Market cap $58.25MP/E –Yield –

OKYO Pharma net income

Net income is the profit left for shareholders after every expense, interest and tax.

No net income figures for OKYO Pharma

OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More OKYO Pharma figures

See a number that looks wrong?